Amgen Wins its Second Patent of the year, Delaying Samsung’s Enbrel Biosim until 2029.
Summary – A U.S. District Court has ruled in favor of Amgen in a patent litigation case involving the drug Enbrel, preventing…
Summary – A U.S. District Court has ruled in favor of Amgen in a patent litigation case involving the drug Enbrel, preventing…
The federal government said on Friday that it will rescind three new contentious agri-laws that have enraged farmers throughout India for nearly…